Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €39.10 and traded as high as €41.42. Fresenius Medical Care shares last traded at €41.15, with a volume of 1,295,024 shares trading hands.
Fresenius Medical Care Stock Performance
The stock has a market capitalization of $12.17 billion, a PE ratio of 18.47, a price-to-earnings-growth ratio of 0.42 and a beta of 0.81. The company has a quick ratio of 0.80, a current ratio of 1.20 and a debt-to-equity ratio of 83.29. The stock has a fifty day moving average of €38.60 and a 200-day moving average of €39.10.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
